0001413898-24-000045.txt : 20240912 0001413898-24-000045.hdr.sgml : 20240912 20240912200612 ACCESSION NUMBER: 0001413898-24-000045 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240912 DATE AS OF CHANGE: 20240912 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DallasNews Corp CENTRAL INDEX KEY: 0001413898 STANDARD INDUSTRIAL CLASSIFICATION: NEWSPAPERS: PUBLISHING OR PUBLISHING & PRINTING [2711] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 383765318 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-84504 FILM NUMBER: 241296180 BUSINESS ADDRESS: STREET 1: 1954 COMMERCE STREET CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-977-7342 MAIL ADDRESS: STREET 1: P.O. BOX 224866 CITY: DALLAS STATE: TX ZIP: 75222-4866 FORMER COMPANY: FORMER CONFORMED NAME: A. H. Belo Corp DATE OF NAME CHANGE: 20210628 FORMER COMPANY: FORMER CONFORMED NAME: DallasNews Corp DATE OF NAME CHANGE: 20210625 FORMER COMPANY: FORMER CONFORMED NAME: A. H. Belo Corp DATE OF NAME CHANGE: 20130206 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DECHERD ROBERT W CENTRAL INDEX KEY: 0000903649 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] ORGANIZATION NAME: STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SCHEDULE 13D/A 1 primary_doc.xml SCHEDULE 13D/A 0000950134-09-002832 0000903649 XXXXXXXX LIVE 11 Series B Common Stock, par value $0.01 per share 09/10/2024 false 0001413898 235050200 DallasNews Corp

P.O. Box 224866 DALLAS TX 75222-4866

Robert W. Decherd (214) 977-8200 P.O. Box 655237 Dallas TX 75265-5237 0000903649 N DECHERD ROBERT W PF N X1 589448.00 1157.00 589448.00 1157.00 590605.00 Y 96.1 IN Series B Common Stock, par value $0.01 per share DallasNews Corp P.O. Box 224866 DALLAS TX 75222-4866 Item 2(b) is amended and restated in its entirety as follows: The principal business address of Mr. Decherd is P.O. Box 655237, Dallas, TX 75265-5237. Item 2(c) is amended and restated in its entirety as follows: Mr. Decherd is the retired Chief Executive Officer and Chairman of the Board of DallasNews Corporation, a Texas corporation (the "Issuer"). Item 3 is amended and supplemented to add the following information: On September 10, 2024, Mr. Decherd acquired 25,000 shares of Series B common stock, par value $0.01 per share, of the Issuer ("Series B Common Stock") from a third-party individual seller in a privately negotiated transaction at a price of $6.00 per share of Series B Common Stock. The source of funds for such transaction was Mr. Decherd's personal funds. Item 4 is amended and supplemented to add the following information: Mr. Decherd acquired the additional 25,000 shares of Series B Common Stock reported in Item 3 of this Amendment No. 11 to Schedule 13D (the "Amendment") for investment purposes. Item 5(a) is amended and restated in its entirety as follows: As of the date of filing of this Amendment, Mr. Decherd beneficially owns an aggregate of 590,605 shares of Series B Common Stock, representing approximately 96.1% of the shares of Series B Common Stock outstanding as of July 25, 2024. This includes (i) 514,376 shares of Series B Common Stock held by Mr. Decherd directly, (ii) 75,072 shares of Series B Common Stock held by the The Decherd Foundation (the "Foundation"), a charitable foundation established by Mr. Decherd and his spouse and for which Mr. Decherd serves as Chairman and director, and (iii) 1,157 shares of Series B Common Stock owned jointly by Mr. Decherd and his spouse. This number does not include 60 shares of Series B Common Stock owned by Mr. Decherd's spouse, as to which Mr. Decherd disclaims beneficial ownership. Item 5(b) is amended and restated in its entirety as follows: As of the date of filing of this Amendment, Mr. Decherd has (i) the sole power to vote and sole dispositive power over 589,448 shares of Series B Common Stock (including 75,072 shares of Series B Common Stock held by the Foundation), and (ii) the shared power to vote and shared dispositive power over 1,157 shares of Series B Common Stock held jointly by Mr. Decherd and his spouse. Item 5(c) is amended and restated in its entirety as follows: Except as disclosed in Item 3 of this Amendment, Mr. Decherd has not effected any other transaction involving shares of Series B Common Stock of the Issuer during the past 60 days. Item 5(d) is amended and restated in its entirety as follows: The Foundation has the right to receive dividends from, and sales proceeds of, the 75,072 shares of Series B Common Stock reported as beneficially owned by Mr. Decherd as Chairman and director of the Foundation. Mr. Decherd's spouse has the right to receive and the power to direct the receipt of dividends from, and sales proceeds of, the 1,157 shares of Series B Common Stock owned jointly by Mr. Decherd and his spouse. Other than as reported in this Item 5(d), no person other than Mr. Decherd has the right to receive or the power to direct the receipt of dividends from, and sales proceeds of, the shares of Series B Common Stock set forth above. Item 5(e) is amended and restated in its entirety as follows: Not applicable. DECHERD ROBERT W /s/ Robert W. Decherd 09/12/2024